Kiromic BiopharmaInc Analysis

Kiromic Stock Analysis Notes

About 68.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 39.68. Kiromic BiopharmaInc had not issued any dividends in recent years. The entity had 1:30 split on the 13th of March 2023. Kiromic BioPharma, Inc., an artificial intelligence driven allogeneic cell therapy company, engages in developing the multi-indication allogeneic T cell therapies that exploits the natural potency of the Gamma Delta T cell to target solid tumors. Kiromic BioPharma, Inc. was founded in 2006 and is headquartered in Houston, Texas. Kiromic Biopharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 59 people. To find out more about Kiromic BiopharmaInc contact JD CPA at 832 968 4888 or learn more at https://www.kiromic.com.

Kiromic BiopharmaInc Investment Alerts

Kiromic BiopharmaInc Upcoming and Recent Events

Kiromic Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 2.15 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Kiromic BiopharmaInc's market, we take the total number of its shares issued and multiply it by Kiromic BiopharmaInc's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Kiromic BiopharmaInc Predictive Daily Indicators

Stock analysis is the technique used by a trader or investor to examine and evaluate how Kiromic BiopharmaInc prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Kiromic shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as Kiromic BiopharmaInc. By using and applying Kiromic Stock analysis, traders can create a robust methodology for identifying Kiromic entry and exit points for their positions.

Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the Kiromic BiopharmaInc information on this page should be used as a complementary analysis to other Kiromic BiopharmaInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

If you are still planning to invest in Kiromic BiopharmaInc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kiromic BiopharmaInc's history and understand the potential risks before investing.